Login Register Cart 0
Generic placeholder image

Current Cancer Therapy Reviews

Editor-in-Chief

ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Serotonin (5HTR2A and 5HTR3A) and GABA (GABAB) Receptor Genes Overexpression are Correlated with Non-small Cell Lung Cancer (NSCLC)

Author(s): Seyed A. Razavi, Besharat Rahimi, Naghmeh Gholipour, Fatemeh Ahangari and Ghasem Ahangari*

Volume 15, Issue 2, 2019

Page: [155 - 161] Pages: 7

DOI: 10.2174/1573394714666180626155751

Price: $65

conference banner
Abstract

Background: Lung cancer is one of the main causes of cancer mortality in both men and women. Up to 80% of lung cancers are Non-small-cell lung cancer (NSCLC). With regards to the role of serotonin, as an autocrine growth factor for small-cell lung cancer cells and gammaaminobutyric acid (GABA) and its receptors as a regulator in many types of cancers; the current study was conducted to investigate the expression of serotonin and GABA gene receptors in lung cancer patients.

Methods: Relative gene expression of two 5-hydroxytryptamine subtypes (5HTR2A and 5-HTR3A) and GABAB receptor was measured by quantitative polymerase chain reaction in peripheral blood mononuclear cell (PBMC) from 30 NSCLC patients visited in Imam Khomeini hospital, Tehran and 30 healthy controls.

Results: Our results demonstrated that the expression of 5HTR3A, 5HTR2A and GABAB R genes was significantly higher in patients compared to the healthy individuals.

Conclusion: According to our findings, 5-HT and GABA may be involved in the regulation of tumorigenesis via their receptors, thus playing an important role in lung cancer.

Keywords: 5HTR2A, 5HTR3A, GABA, serotonin, receptor, non-small-cell lung cancer (NSCLC).

« Previous Next »
Graphical Abstract

[1]
Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008; 123(1): 1-7.
[2]
Larsen JE, Minna JD. Molecular biology of lung cancer: Clinical implications. Clin Chest Med 2011; 32(4): 703-40.
[3]
Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20(1): 125-63.
[4]
Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system and cancer. Lancet Oncol 2004; 5(10): 617-25.
[5]
Ahangari G, Amirabad LM, Mozafari S, Majeidi A, Deilami GD. Investigation of 5-HT3A receptor gene expression in peripheral blood mononuclear cells of individuals who had been exposed to air pollution. Inflamm Allergy Drug Targets 2013; 12(6): 433-8.
[6]
Amirabad LM, Ahangari G, Deilami GD. Significant changes of 5-hydroxytriptamine 3A receptor gene expression in peripheral blood mononuclear cells of allergic asthmatic patients. Iran J Allergy Asthma Immunol 2014; 13(1): 33.
[7]
Vicentini LM, Cattaneo MG, Fesce R. Evidence for receptor subtype cross-talk in the mitogenic action of serotonin on human small-cell lung carcinoma cells. Eur J Pharmacol 1996; 318(2-3): 497-504.
[8]
Pinquart M, Duberstein P. Depression and cancer mortality: A meta-analysis. Psychol Med 2010; 40(11): 1797-810.
[9]
Azmitia EC. Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation and apoptosis. Brain Res Bull 2001; 56(5): 413-24.
[10]
Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008; 195(1): 198-213.
[11]
Cogolludo A, Moreno L, Lodi F, et al. Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: Role of 5-HT2A receptors, caveolin-1 and KV1. 5 channel internalization. Circulat Res 2006; 98(7): 931-8.
[12]
Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P. The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Cα. Biochim Biophys Acta 2003; 1640(1): 85-96.
[13]
Wu C, Sun D. GABA receptors in brain development, function and injury. Metab Brain Dis 2015; 30(2): 367-79.
[14]
Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABAB receptors. Physiol Rev 2004; 84(3): 835-67.
[15]
Li Y-H, Liu Y, Li Y-D, et al. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. World J Gastroenterol 2012; 18(21): 2704.
[16]
Khan NA, Hichami A. Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells. Biochem J 1999; 344(Pt 1): 199.
[17]
Young SZ, Bordey A. GABA’s control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology 2009; 24(3): 171-85.
[18]
Hejazi SH, Ahangari G, Pornour M, et al. Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pac J Cancer Prev 2013; 15(11): 4455-8.
[19]
Pornour M, Ahangari GH, Hejazi S, Deezagi A. New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line. Recent Patents Anticancer Drug Discov 2015; 10(2): 214-23.
[20]
Herbert TB, Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosom Med 1993; 55(4): 364-79.
[21]
Siddiqui EJ, Thompson CS, Mikhailidis DP, Mumtaz FH. The role of serotonin in tumour growth. Oncol Rep 2005; 14(6): 1593-7.
[22]
Ahangari G, Emadi Koochak S, Mohammadi Amirabad L, Derkhshan Deilami G. Investigation of 5-HT2A gene expression in PBMCs of patients with allergic asthma. Inflamm Allergy Drug Targets 2015; 14(1): 60-4.
[23]
Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 2010; 6(3): 205-12.
[24]
Seuwen K, Pouysségur J. Serotonin as a growth factor. Biochem Pharmacol 1990; 39(6): 985-90.
[25]
Horai T, Nishihara H, Tateishi R, Matsuda M, Hattori S. Oat-cell carcinoma of the lung simultaneously producing ACTH and serotonin. J Clin Endocrinol Metab 1973; 37(2): 212-9.
[26]
Cattaneo MG, Codignola A, Vicentini LM, Clementi F, Sher E. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res 1993; 53(22): 5566-8.
[27]
Cattaneo MG, Fesce R, Vicentini LM. Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. European J Pharmacol Mol Pharmacol 1995; 291(2): 209-11.
[28]
Cattaneo MG, Palazzi E, Bondiolotti G, Vicentini LM. 5-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma. European J Pharmacol Mol Pharmacol 1994; 268(3): 425-30.
[29]
Sheehan PF, Baker T, Tutton PJ, Barkla DH. Effects of histamine and 5‐hydroxytryptamine on the growth rate of xenografted human bronchogenic carcinomas. Clin Exp Pharmacol Physiol 1996; 23(6‐7): 465-71.
[30]
Pratesi G, Cervi S, Balsari A, Bondiolotti G, Vicentini L. Effect of serotonin and nicotine on the growth of a human small cell lung cancer xenograft. Anticancer Res 1996; 16(6B): 3615-9.
[31]
Zhang X, Zhang R, Zheng Y, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med 2013; 11(1): 102.
[32]
Schuller HM, Al-Wadei HA, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 2008; 29(10): 1979-85.
[33]
Al-Wadei HA, Al-Wadei MH, Schuller HM. Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: A novel target for intervention. PLoS One 2012; 7(1)e29915
[34]
Wang T, Huang W, Chen F. Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. Life Sci 2008; 82(9-10): 536-41.

Rights & Permissions Print Cite
Article Metrics
55
4
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy